Myelofibrosis epidemiology

View All

Myelofibrosis Therapeutics Market 
Myelofibrosis Therapeutics Market

Myelofibrosis (MF) is a rare type of bone marrow cancer resulting in abnormal functioning of blood-forming cells and fibres. MF belongs to a group of disorders known as myeloproliferative disorders. This condition results in the widespread scarring of bone marrow leading to anaemia decreased count of platelets, and...

Find More